Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -119,857 | N/A | 3,427,000 | 2,769,000 | 2,113,000 |
| Depreciation Amortization | 10,755 | N/A | 592,000 | 492,000 | 407,000 |
| Income taxes - deferred | N/A | N/A | 90,000 | -234,000 | -112,000 |
| Accounts receivable | -1,843 | N/A | -132,000 | 38,000 | -628,000 |
| Accounts payable and accrued liabilities | 664 | N/A | N/A | N/A | N/A |
| Other Working Capital | 10,577 | N/A | -204,000 | -77,000 | -385,000 |
| Other Operating Activity | 55,041 | 0 | 182,000 | 242,000 | 743,000 |
| Operating Cash Flow | $-44,663 | $N/A | $3,955,000 | $3,230,000 | $2,138,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22,219 | N/A | -751,000 | -977,000 | -1,214,000 |
| Net Acquisitions | N/A | N/A | N/A | -833,000 | N/A |
| Purchase Of Investment | -50,133 | N/A | -2,980,000 | -1,152,000 | -1,036,000 |
| Sale Of Investment | N/A | N/A | 2,049,000 | 1,137,000 | 613,000 |
| Purchase Sale Intangibles | N/A | N/A | 15,000 | -40,000 | 9,000 |
| Other Investing Activity | -2,250 | 0 | 15,000 | -40,000 | -44,000 |
| Investing Cash Flow | $-74,602 | $N/A | $-1,667,000 | $-1,865,000 | $-1,681,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -99,000 | 599,000 | N/A |
| Debt Repayment | -352 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 7 | N/A | 680,000 | 452,000 | 385,000 |
| Common Stock Repurchased | -408 | N/A | -780,000 | -1,345,000 | -996,000 |
| Other Financing Activity | 411,138 | 0 | -70,000 | 193,000 | 179,000 |
| Financing Cash Flow | $410,385 | $N/A | $-269,000 | $-101,000 | $-432,000 |
| Beginning Cash Position | 207,390 | N/A | 2,514,000 | 1,250,000 | 1,225,000 |
| End Cash Position | 498,510 | N/A | 4,533,000 | 2,514,000 | 1,250,000 |
| Net Cash Flow | $291,120 | $N/A | $2,019,000 | $1,264,000 | $25,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,663 | N/A | 3,955,000 | 3,230,000 | 2,138,000 |
| Capital Expenditure | -22,219 | N/A | -751,000 | -977,000 | -1,214,000 |
| Free Cash Flow | -66,882 | 0 | 3,204,000 | 2,253,000 | 924,000 |